CompoAtlas

PENTAOPHYT Tonifiant Maître du Coeur

Food supplement declared in France, decision dated 6 June 2025

PENTAOPHYT Tonifiant Maître du Coeur is a food supplement declared in France. Status: declared in France, may be marketed. 1 rule of use applies to its ingredients (limits and warnings).

Brand
not provided
Food business operator placing the product on the market
LABORATOIRE D'AROMATHERAPIE DE PHYTOTHERAPIE ET D'HERBORISTERIE TRADITIONNELLE - PHYTOFRANCE (LAPHT PHYTOFRANCE) (L.A.P.H.T. PHYTOFRAN)
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Bottle
Daily dose
3 cuillérée à café. (15ml)
Directions for use
1 cuillérée à café dans un verre d'eau. 3 fois par jour avant les repas. Agiter avant utilisation.
Intended populations
Men and women aged 18 and over
Not recommended (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Autre : Médecine traditionnelle chinoise - Maître du Cœur., Femmes enceintes, Sous anticoagulants, Sous antidépresseurs, Sous traitement médicamenteux
Objectives stated by the manufacturer (these are not authorised claims)
Autre : Médecine traditionnelle chinoise - Maître du Cœur.

Declaration 332204, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Vitis vinifera L.FeuilleExtrait fluide hydroalcoolique118.95 mg
Satureja montana L.Parties aériennesExtrait fluide hydroalcoolique118.95 mg
Achillea millefolium L.Parties aériennesExtrait fluide hydroalcoolique95.1 mg
Ginkgo biloba L.FeuilleExtrait fluide hydroalcoolique71.4 mg
Mentha spicata L.FeuilleExtrait fluide hydroalcoolique47.55 mg
Zingiber officinale RoscoeRhizomeExtrait fluide hydroalcoolique23.85 mg

Other active ingredients

NamePer day
mielnot declared

Additives

E422

Other ingredients

Alcool éthylique, Eau purifiée

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Réservé aux adultes. Déconseillé aux femmes enceintes ou allaitantes. Déconseillé en cas d’allergie croisée connue, en particulier aux plantes de la famille des Asteraceae. En cas de traitement médicamenteux, demander conseil à un professionnel de santé. Consultez votre médecin en cas de prise simultanée d’anticoagulants. Déconseillé en cas de prise d’antidépresseurs. Déconseillé en cas d’épilepsie. Déconseillé en cas d’acte interventionnel invasif programmé.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ginkgo biloba L.
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Sources cited by Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 25 July 2025

  • Zingiber officinale Roscoe
    Read the warning, when it applies and the studies cited

    GINGER - ZINGIBER OFFICINALE

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 19 December 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line